NPI registry status
Active
2026 NPPES data Dermatology Physician NPI 1851633242 M.D.
Verify on CMS → Lawrence Feigenbaum, M.D.
Dermatology Physician in Cape Girardeau, Missouri.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 14,645 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 501 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
97%
generic claims · 3% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$2.8K
189 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Lawrence Feigenbaum, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,304 Medicare Part D claims in 2023.
- 75/100
- CMS neutral score · not measured
- 1K
- Part D claims, 2023
- 97%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Lawrence Feigenbaum, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1851633242), first enumerated 03/23/2013.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,304 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$2.8K in reported industry payments (189 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1851633242 · Dermatology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1851633242
- ENUM-MID 2013
- TAX-MID 15K Dermatology Physician
- MIPS-NEUTRAL 75/100
- RX-MID 1,304
- BOOK-THIN 245 in Missouri
- PHOTO-ENUM Amir Zahir · 2013
Lawrence Feigenbaum, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,304 ≥ 79th percentile 79% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Lawrence Feigenbaum, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lawrence Feigenbaum, M.D.?
CMS neutral score, not measuredPrimary specialty
Dermatology Physician
Medicare Part D claims
1,304 79% vs specialty avg
MIPS final score
75/100
Specialty distribution in Missouri
How Dermatology Physician compares to other specialties among Missouri providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1851633242 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 03/23/2013 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Hospital and facility affiliations
Facilities where Lawrence Feigenbaum, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Alliance Health And Dermatology, LLC
Cape Girardeau, MO
Mid-County Dermatology, Inc
Saint Louis, MO
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lawrence Feigenbaum, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.8K
Largest payer
Janssen Biotech, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Lawrence Feigenbaum, M.D. - brand share 3.0%
Dermatology Physician average
3% brand-name claims vs 97% generic, on 1,304 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,304
Total Claims
$156K
Total Drug Cost
501
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,732
- Total Day Supply
- 43,826
- Brand vs Generic
- 3% brand / 97% generic
- Brand Drug Cost
- $124K
- Generic Drug Cost
- $32K
- Antibiotic Claims
- 106
Patient Demographics
- Average Patient Age
- 74.2 years
- Avg HCC Risk Score
- 1.22
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 42, 65-74: 212, 75-84: 177, 85+: 70
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Lawrence Feigenbaum, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Triamcinolone Acet…
Triamcinolone Acetonide
236 claims
- Minoxidil
Minoxidil
113 claims
- Mometasone Furoate 92
Mometasone Furoate
92 claims
- Clobetasol Propion… 75
Clobetasol Propionate
75 claims
- Betamethasone Dipr… 73
Betamethasone Dipropionate
73 claims
- Dexamethasone 57
Dexamethasone
57 claims
- Prednisone 55
Prednisone
55 claims
- Doxycycline Hyclate 52
Doxycycline Hyclate
52 claims
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 236 |
| Minoxidil | 113 |
| Mometasone Furoate | 92 |
| Clobetasol Propionate | 75 |
| Betamethasone Dipropionate | 73 |
| Dexamethasone | 57 |
| Prednisone | 55 |
| Doxycycline Hyclate | 52 |
| Fluconazole | 47 |
| Doxepin Hcl | 45 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Lawrence Feigenbaum, M.D. fits within the Dermatology Physician landscape nationally.
14,645
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider
Lawrence Feigenbaum, M.D.'s 1,304 claims are above the specialty average of 729.
Nationwide Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Feigenbaum, both outside Missouri so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2013)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatology Physician Providers in Missouri
Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Feigenbaum.
One of 245 Dermatology Physician providers enrolled in Missouri, 5 are shown here.
Dr. Mallory Abate
M.D.
Saint Louis, MO
Dr. Benjamin Adams
D.O.
Kirksville, MO
Anna Aiazzi
Saint Louis, MO
Dr. Osaigbokan Aihie
MD
Columbia, MO
Dr. Susan Ailor
MD
Columbia, MO
Compare Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Lawrence Feigenbaum, M.D.'s specialty? ▼
Lawrence Feigenbaum, M.D. specializes in Dermatology Physician and practices in Cape Girardeau, Missouri. Credentials: M.D..
How much does Lawrence Feigenbaum, M.D. prescribe under Medicare Part D? ▼
In 2023, Lawrence Feigenbaum, M.D. wrote 1,304 Medicare Part D claims totaling $156K in drug costs for 501 beneficiaries.
What is Lawrence Feigenbaum, M.D.'s Medicare quality score? ▼
Lawrence Feigenbaum, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Lawrence Feigenbaum, M.D. located? ▼
Lawrence Feigenbaum, M.D. is located at 304 S MOUNT AUBURN RD, Cape Girardeau, MO, 63703. Phone: (573) 803-3331.
What is Lawrence Feigenbaum, M.D.'s NPI number? ▼
Lawrence Feigenbaum, M.D.'s National Provider Identifier (NPI) is 1851633242, issued on 03/23/2013.
Does Lawrence Feigenbaum, M.D. prescribe more brand-name or generic drugs? ▼
Lawrence Feigenbaum, M.D.'s prescribing is 3% brand-name and 97% generic drugs by claim count, with $124K in brand drug costs.
How many Dermatology Physician providers are there in the US? ▼
There are 14,645 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does Lawrence Feigenbaum, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Lawrence Feigenbaum, M.D.'s most frequently prescribed drugs include Triamcinolone Acetonide, Minoxidil, Mometasone Furoate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lawrence Feigenbaum, M.D. accept Medicare? ▼
Lawrence Feigenbaum, M.D. appears in CMS Medicare data with 1,304 Part D claims and 501 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lawrence Feigenbaum, M.D.'s credentials? ▼
Lawrence Feigenbaum, M.D.'s NPI is 1851633242 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.